Stefan Gabriel, Garneata Liliana, Tacu Dorina, Bucsa Cristina, Sinescu Ioanel, Mircescu Gabriel
Department of Nephrology, "Dr. Carol Davila" University Hospital of Nephrology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Center of Uronephrology and Renal Transplantation, Fundeni Clinical Institute, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Maedica (Bucur). 2015 Sep;10(4):304-309.
According to the Romanian Renal Registry (RRR), only 8% of patients on renal replacement therapy (RRT) in 2012 received a kidney transplant (KTx). As not all transplant centers report to RRR, the outcome of transplanted patients in Romania is not known. Therefore, we aimed to evaluate the outcome in patients grafted in one of the largest transplant center in the country as compared to hemodialysis (HD) and peritoneal dialysis (PD) patients recorded by the RRR.
In an intention-to-treat analysis using Kaplan-Meier and Cox proportional hazard (CPH) models, survival was compared between 8050 incident HD, 1000 PD and 490 KTx patients treated between 2008 and 2011. The patients were stratified by modality at day 90 of therapy.
As compared to HD and PD patients, the KTx recipients were younger, more often of male gender, and had glomerulonephritis as primary renal disease (PRD) more frequently. KTx patients had a higher mean survival time (57.68 [56.95-58.42] months) than HD (45.55 [45.04- 46.06] months) or PD patients (46.33 [45.01-47.65] months). In the multivariate CPH model, higher age (OR=1.03 (1.02-1.03), p<0.01) at RRT initiation, HD (OR=5.60 (3.16-9.94), p<0.01) and PD (OR=5.62 (3.14-10.08), p<0.01) as RRT and diabetic nephropathy (p<0.01) as PRD were associated with a poorer survival.
The present study is the first to provide representative information about the outcome of the KTx patients in Romania. We found that patient survival after KTx is markedly better than either HD or PD. Urgent implementation of a KTx registry is needed in order to improve the national transplantation program.
根据罗马尼亚肾脏登记处(RRR)的数据,2012年接受肾脏替代治疗(RRT)的患者中只有8%接受了肾移植(KTx)。由于并非所有移植中心都向RRR报告数据,罗马尼亚移植患者的治疗结果尚不清楚。因此,我们旨在评估该国最大的移植中心之一的移植患者与RRR记录的血液透析(HD)和腹膜透析(PD)患者相比的治疗结果。
在一项使用Kaplan-Meier和Cox比例风险(CPH)模型的意向性分析中,比较了2008年至2011年间接受治疗的8050例新发HD患者、1000例PD患者和490例KTx患者的生存率。患者在治疗第90天时按治疗方式分层。
与HD和PD患者相比,KTx受者更年轻,男性比例更高,原发性肾病(PRD)为肾小球肾炎的情况更常见。KTx患者的平均生存时间(57.68[56.95-58.42]个月)高于HD患者(45.55[45.04-46.06]个月)或PD患者(46.33[45.01-47.65]个月)。在多变量CPH模型中,RRT开始时年龄较大(OR=1.03[1.02-1.03],p<0.01)、RRT为HD(OR=5.60[3.16-9.94],p<0.01)和PD(OR=5.62[3.14-10.08],p<0.01)以及PRD为糖尿病肾病(p<0.01)与较差的生存率相关。
本研究首次提供了罗马尼亚KTx患者治疗结果的代表性信息。我们发现KTx后的患者生存率明显优于HD或PD。需要紧急实施KTx登记系统以改善国家移植计划。